Martin G. Sanda

Also affiliated with Emory University Hospital

MedicinePhysics and AstronomyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 20 papers. Top paper: “Differentiation fate of a stem-like CD4 T cell controls immunity to cancer”.

Differentiation fate of a stem-like CD4 T cell controls immunity to cancer

Nature(2024)10.1038/s41586-024-08076-7

N/A

1.1DataRank · unranked

57 citations

Nataliya Prokhnevska, Ewelina Sobierajska, Petra Gregorova, Christopher B. Medina, Rajesh M. Valanparambil +9 more

Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2020.11.038

N/A

1.1DataRank · unranked

21 citations

Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Niya Xiong, Christopher P. Filson +12 more

Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy

The Prostate(2019)10.1002/pros.23803

N/A

0.533DataRank · unranked

34 citations

Manish Vira, Vonn Walter, Jing Shen, Jay D. Raman, Martin G. Sanda +3 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0.477DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0.406DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Cost‐effectiveness analysis of primary treatments for localised prostate cancer: A population‐based Markov analysis using real‐world evidence

European Journal of Cancer Care(2022)10.1111/ecc.13740

N/A

0.208DataRank · unranked

3 citations

Lixian Zhong, Xiang Pin, Yiyuan Li, Alan Paciorek, Liangliang Dong +5 more

Covariate‐specific evaluation of continuous biomarker

Statistics in Medicine(2023)10.1002/sim.9652

N/A

0.165DataRank · unranked

2 citations

Yijian Huang, Dattatraya Patil, Mark A. Rubin, Martin G. Sanda, Ziyi Li

A simplified MyProstateScore2.0 for high-grade prostate cancer

Cancer Biomarkers(2025)10.1177/18758592241308755

N/A

0.104DataRank · unranked

1 citations

Yuping Zhang, Ana Kenney, Cassie Xie, Lanbo Xiao, Javed Siddiqui +10 more

Data from Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

(2023)10.1158/1078-0432.c.6517356

N/A

0DataRank · unranked

0 citations

Bin Lu, Manoj Bhasin, Miriam Eljanne, Wen Yue, Juan‐Miguel Mosquera +6 more

Data from Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

(2023)10.1158/1078-0432.c.6517356.v1

N/A

0DataRank · unranked

0 citations

Bin Lu, Manoj Bhasin, Miriam Eljanne, Wen Yue, Juan‐Miguel Mosquera +6 more

Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States

Cancer(2025)10.1002/cncr.35795

N/A

0DataRank · unranked

6 citations

Dattatraya Patil, Pretesh Patel, Ashesh B. Jani, Bruce Hershatter, Vishal R. Dhere +7 more

Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group

European Urology(2025)10.1016/j.eururo.2025.11.013

N/A

0DataRank · unranked

0 citations

Samson W. Fine, Jorg R. Oddens, Auke Jager, Arnoud W. Postema, Harrie P. Beerlage +86 more

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03210-8

N/A

0DataRank · unranked

5 citations

Lydia Lynch, Lianne Vriend, Dobrin Draganov, Justice Clark, Haydn Kissick +7 more

In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US–guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers

Radiology Imaging Cancer(2020)10.1148/rycan.2020190078

N/A

0DataRank · unranked

9 citations

Christopher P. Filson, Martin G. Sanda, Adeboye O. Osunkoya, Sherif G. Nour, Kareem Elfatairy

Covariate adjustment in continuous biomarker assessment

Biometrics(2021)10.1111/biom.13601

N/A

0DataRank · unranked

3 citations

Yijian Huang, Dattatraya Patil, Martin G. Sanda, Ziyi Li

Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.07.013

N/A

0DataRank · unranked

1 citations

Dattatraya Patil, Martin G. Sanda, Christopher P. Filson, Jonathan Li

Association of race with receipt of definitive therapy for high risk prostate cancer in older men

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.09.012

N/A

0DataRank · unranked

2 citations

Yuan Liu, Brandon A. Mahal, Ashesh B. Jani, Martin G. Sanda, Trevor J. Royce +2 more

Interval Estimation for Operating Characteristic Of Continuous Biomarkers With Controlled Sensitivity or Specificity

Statistica Sinica(2021)10.5705/ss.202021.0020

N/A

0DataRank · unranked

0 citations

Isaac Parakati, Dattatraya Patil, Martin G. Sanda, Yijian Huang

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

Immunity(2022)10.1016/j.immuni.2022.12.002

N/A

0DataRank · unranked

350 citations

Maria A. Cardenas, Rajesh M. Valanparambil, Ewelina Sobierajska, Benjamin G. Barwick, Caroline S. Jansen +13 more

Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1104

N/A

0DataRank · unranked

17 citations

Robin J. Leach, Martin G. Sanda, O. John Semmes, Michael A. Liss